SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-21-015647
Filing Date
2021-08-04
Accepted
2021-08-04 20:01:30
Documents
1
Period of Report
2021-06-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_162812167372819.html 4  
1 FORM 4 wf-form4_162812167372819.xml 4 4257
  Complete submission text file 0001628280-21-015647.txt   5734
Mailing Address 425 PONTIUS AVE N, STE 202 SEATTLE WA 98109
Business Address 425 PONTIUS AVE N, STE 202 SEATTLE WA 98109 206-333-2001
Nautilus Biotechnology, Inc. (Issuer) CIK: 0001808805 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 6770 Blank Checks

Mailing Address C/O NAUTILUS BIOTECHNOLOGY, INC. 425 PONTIUS AVE N, STE 202 SEATTLE WA 98109
Business Address
Murphy Matthew B. (Reporting) CIK: 0001865778 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39434 | Film No.: 211145810